Law Ernest, Harrington Rachel, Alexander G Caleb, Saha Soumi, Oehrlein Elisabeth, Perfetto Eleanor M
Department of Pharmacy Systems, Outcomes & Policy, University of Illinois at Chicago, Chicago, IL 60612, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
J Comp Eff Res. 2018 Feb;7(2):181-191. doi: 10.2217/cer-2017-0060. Epub 2018 Feb 21.
The goal of comparative effectiveness research (CER) and patient-centered outcomes research (PCOR) is to improve health outcomes by providing stakeholders with evidence directly relevant to decision making. In January 2017, the Pharmaceutical Research and Manufacturers Association Foundation, alongside the Academy for Managed Care Pharmacy, organized a conference aimed at engaging experts and opinion leaders representing clinicians, patients and payers to identify and discuss barriers and strategies to enhancing uptake and use of CER/PCOR. This report summarizes the conference discussion in the following sections: preconference survey; summary of barriers and strategies to the uptake of CER/PCOR identified by conference attendees; and future perspectives on the field.
比较效果研究（CER）和以患者为中心的结果研究（PCOR）的目标是通过向利益相关者提供与决策直接相关的证据来改善健康结果。2017年1月，药品研究和制造商协会基金会与管理式医疗药学学会共同组织了一次会议，旨在让代表临床医生、患者和支付方的专家和意见领袖参与进来，以识别和讨论增强CER/PCOR的采用和使用的障碍及策略。本报告在以下章节总结了会议讨论内容：会前调查；会议参与者识别出的CER/PCOR采用的障碍及策略总结；以及该领域的未来展望。
